Larry T. Mullen

N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat.

Richard C. Moon, Henry J. Thompson, Peter J. Becci et al. · PubMed · 1979 · 385 citations

Ocular Disease, Retina, Ophthalmology +15

Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.

Mario A. Anzano, Stephen W. Byers, Joseph M. Smith et al. · PubMed · 1994 · 198 citations

Breast Oncology, Pathology, Tumor Biology +16

Chemoprevention of Mammary Carcinogenesis in the Rat: Combined Use of Raloxifene and 9-cis-Retinoic Acid

Mario A. Anzano, Christopher W. Peer, Joseph M. Smith et al. · JNCI Journal of the National Cancer Institute · 1996 · 171 citations

Breast Oncology, Chemoprevention Strategy, Medicine +12

1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.

Mario A. Anzano, Joseph M. Smith, Milan R. Uskoković et al. · PubMed · 1994 · 137 citations

Medicinal Chemistry, Oncology, Endocrine-related Cancer +15

Localization of transforming growth factor-β isotypes in lesions of the human breast

Bryan K. McCune, Brian R. Mullin, Kathleen C. Flanders et al. · Human Pathology · 1992 · 102 citations

Human Breast, Breast Oncology, Human Growth +8